相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。G protein-coupled receptor GPR55 promotes colorectal cancer and has opposing effects to cannabinoid receptor 1
Carina Hasenoehrl et al.
INTERNATIONAL JOURNAL OF CANCER (2018)
Cannabinoid receptor 2 as a novel target for promotion of renal cell carcinoma prognosis and progression
Jianfeng Wang et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2018)
Targeting the endocannabinoid system as a potential anticancer approach
Rico Schwarz et al.
DRUG METABOLISM REVIEWS (2018)
Cannabinoid-induced cell death in endometrial cancer cells: involvement of TRPV1 receptors in apoptosis
B. M. Fonseca et al.
JOURNAL OF PHYSIOLOGY AND BIOCHEMISTRY (2018)
Systematic review and meta-analysis of cannabinoids in palliative medicine
Martin Muecke et al.
JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2018)
Optimization of a preclinical therapy of cannabinoids in combination with temozolomide against glioma
Israel Lopez-Valero et al.
BIOCHEMICAL PHARMACOLOGY (2018)
Structural and Functional Interaction of Delta(9)-Tetrahydrocannabinol with Liver Fatty Acid Binding Protein (FABP1)
Huan Huang et al.
BIOCHEMISTRY (2018)
The Endocannabinoid/Cannabinoid Receptor 2 System Protects Against Cisplatin-Induced Hearing Loss
Sumana Ghosh et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2018)
Report of Objective Clinical Responses of Cancer Patients to Pharmaceutical-grade Synthetic Cannabidiol
Julian Kenyon et al.
ANTICANCER RESEARCH (2018)
Fatty acid-binding protein FABP4 mechanistically links obesity with aggressive AML by enhancing aberrant DNA methylation in AML cells
F. Yan et al.
LEUKEMIA (2017)
Exogenous FABP4 increases breast cancer cell proliferation and activates the expression of fatty acid transport proteins
Sandra Guaita-Esteruelas et al.
MOLECULAR CARCINOGENESIS (2017)
Pharmacological inhibition of MAGL attenuates experimental colon carcinogenesis
Ester Pagano et al.
PHARMACOLOGICAL RESEARCH (2017)
Cannabidiol, a novel inverse agonist for GPR12
Kevin J. Brown et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2017)
N-acyl dopamines induce apoptosis in PC12 cell line via the GPR55 receptor activation
M. G. Akimov et al.
DOKLADY BIOCHEMISTRY AND BIOPHYSICS (2017)
Development of new inhibitors for N-acylethanolamine-hydrolyzing acid amidase as promising tool against bladder cancer
Riccardo Vago et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2017)
Quantitative Analyses of Synergistic Responses between Cannabidiol and DNA-Damaging Agents on the Proliferation and Viability of Glioblastoma and Neural Progenitor Cells in Culture
Liting Deng et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2017)
The cancer-promoting gene fatty acid-binding protein 5 (FABP5) is epigenetically regulated during human prostate carcinogenesis
Koichiro Kawaguchi et al.
BIOCHEMICAL JOURNAL (2016)
Identification of N-arachidonoyl dopamine as a highly biased ligand at cannabinoid CB1 receptors
William J. Redmond et al.
BRITISH JOURNAL OF PHARMACOLOGY (2016)
GPR55 promotes migration and adhesion of colon cancer cells indicating a role in metastasis
J. Kargl et al.
BRITISH JOURNAL OF PHARMACOLOGY (2016)
Peroxisome Proliferator-Activated Receptor-α Inhibition Protects Against Doxorubicin-Induced Cardiotoxicity in Mice
Mahdieh Rahmatollahi et al.
CARDIOVASCULAR TOXICOLOGY (2016)
被撤回的出版物: Anti-carcinogenic activity of anandamide on human glioma in vitro and in vivo (Retracted article. See vol. 27, 2023)
Chao Ma et al.
MOLECULAR MEDICINE REPORTS (2016)
FABP1: A Novel Hepatic Endocannabinoid and Cannabinoid Binding Protein
Huan Huang et al.
BIOCHEMISTRY (2016)
5-lipoxygenase mediates docosahexaenoyl ethanolamide and N-arachidonoyl-L-alanine-induced reactive oxygen species production and inhibition of proliferation of head and neck squamous cell carcinoma cells
Seok-Woo Park et al.
BMC CANCER (2016)
The novel, orally available and peripherally restricted selective cannabinoid CB2 receptor agonist LEI-101 prevents cisplatin-induced nephrotoxicity
Partha Mukhopadhyay et al.
BRITISH JOURNAL OF PHARMACOLOGY (2016)
Fatty acid binding protein (FABP) inhibitors: a patent review (2012-2015)
Yan-Ting Wang et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2016)
Antitumorigenic targets of cannabinoids - current status and implications
Robert Ramer et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2016)
Monoacylglycerol lipase promotes progression of hepatocellular carcinoma via NF-κB-mediated epithelial-mesenchymal transition
Weiping Zhu et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2016)
FABP-1 gene ablation impacts brain endocannabinoid system in male mice
Gregory G. Martin et al.
JOURNAL OF NEUROCHEMISTRY (2016)
Comparing the effects of endogenous and synthetic cannabinoid receptor agonists on survival of gastric cancer cells
A. Ortega et al.
LIFE SCIENCES (2016)
Female Mice are Resistant to Fabp1 Gene Ablation-Induced Alterations in Brain Endocannabinoid Levels
Gregory G. Martin et al.
LIPIDS (2016)
Palmitoylethanolamide Exerts Antiproliferative Effect and Downregulates VEGF Signaling in Caco-2 Human Colon Carcinoma Cell Line Through a Selective PPAR--Dependent Inhibition of Akt/mTOR Pathway
Giovanni Sarnelli et al.
PHYTOTHERAPY RESEARCH (2016)
Endocannabinoids and endocannabinoid-related mediators: Targets, metabolism and role in neurological disorders
Fabio Arturo Iannotti et al.
PROGRESS IN LIPID RESEARCH (2016)
FABP5 correlates with poor prognosis and promotes tumor cell growth and metastasis in cervical cancer
Wei Wang et al.
TUMOR BIOLOGY (2016)
Overexpression of cannabinoid receptor 1 promotes renal cell carcinoma progression
Jianfeng Wang et al.
TUMOR BIOLOGY (2016)
Fatty acid amide hydrolase inhibitors confer anti-invasive and antimetastatic effects on lung cancer cells
Katrin Winkler et al.
ONCOTARGET (2016)
Cannabinoids synergize with carfilzomib, reducing multiple myeloma cells viability and migration
Massimo Nabissi et al.
ONCOTARGET (2016)
Liver fatty acid-binding protein (L-FABP) promotes cellular angiogenesis and migration in hepatocellular carcinoma
Chung-Yu Ku et al.
ONCOTARGET (2016)
Fatty acid activated PPARγ promotes tumorigenicity of prostate cancer cells by up regulating VEGF via PPAR responsive elements of the promoter
Farzad S. Forootan et al.
ONCOTARGET (2016)
GPR18 undergoes a high degree of constitutive trafficking but is unresponsive to N-Arachidonoyl Glycine
David B. Finlay et al.
PEERJ (2016)
Modulation of breast cancer cell viability by a cannabinoid receptor 2 agonist, JWH-015, is calcium dependent
Katherine E. Hanlon et al.
BREAST CANCER-TARGETS AND THERAPY (2016)
Integrating cannabis into clinical cancer care
D. I. Abrams
CURRENT ONCOLOGY (2016)
Cannabinoid Receptor 1 Promotes Hepatocellular Carcinoma Initiation and Progression Through Multiple Mechanisms
Bani Mukhopadhyay et al.
HEPATOLOGY (2015)
Cannabidiol stimulates Aml-1a-dependent glial differentiation and inhibits glioma stem-like cells proliferation by inducing autophagy in a TRPV2-dependent manner
Massimo Nabissi et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Cannabinoids for Medical Use A Systematic Review and Meta-analysis
Penny F. Whiting et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)
Inhaled Cannabis for Chronic Neuropathic Pain: A Meta-analysis of Individual Patient Data
Michael H. Andreae et al.
JOURNAL OF PAIN (2015)
Efficacy of Inhaled Cannabis on Painful Diabetic Neuropathy
Mark S. Wallace et al.
JOURNAL OF PAIN (2015)
Role of Cannabinoid Receptor CB2 in HER2 Pro-oncogenic Signaling in Breast Cancer
Eduardo Perez-Gomez et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
Differential role of cannabinoids in the pathogenesis of skin cancer
Nicole Glodde et al.
LIFE SCIENCES (2015)
Fatty acid binding protein deletion suppresses inflammatory pain through endocannabinoid/N-acylethanolamine-dependent mechanisms
Martin Kaczocha et al.
MOLECULAR PAIN (2015)
Proapoptotic effect of endocannabinoids in prostate cancer cells
O. Orellana-Serradell et al.
ONCOLOGY REPORTS (2015)
Endocannabinoid and ceramide levels are altered in patients with colorectal cancer
Ling Chen et al.
ONCOLOGY REPORTS (2015)
Kruppel-like factor 2 suppresses mammary carcinoma growth by regulating retinoic acid signaling
Wei Zhang et al.
ONCOTARGET (2015)
Role of Cannabinoid Receptor CB2 in HER2 Pro-oncogenic Signaling in Breast Cancer
Eduardo Perez-Gomez et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
Anticancer effects of anandamide on head and neck squamous cell carcinoma cells via the production of receptor-independent reactive oxygen species
Seok-Woo Park et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2015)
Cannabinoid receptor type 1 immunoreactivity and disease severity in human epithelial ovarian tumors
Enrico Michelino Messalli et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2014)
Cannabinoids increase lung cancer cell lysis by lymphokine-activated killer cells via upregulation of ICAM-1
Maria Haustein et al.
BIOCHEMICAL PHARMACOLOGY (2014)
Colon carcinogenesis is inhibited by the TRPM8 antagonist cannabigerol, a Cannabis-derived non-psychotropic cannabinoid
Francesca Borrelli et al.
CARCINOGENESIS (2014)
Fatty acid binding proteins: tissue-specific functions in health and disease
Alfred E. Thumser et al.
CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE (2014)
The effects of cannabidiol and its synergism with bortezomib in multiple myeloma cell lines. A role for transient receptor potential vanilloid type-
Maria Beatrice Morelli et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
Exogenous fatty acid binding protein 4 promotes human prostate cancer cell progression
Hisanori Uehara et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
The expression of C-FABP and PPAR gamma and their prognostic significance in prostate cancer
Farzad S. Forootan et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2014)
Targeting CB2-GPR55 Receptor Heteromers Modulates Cancer Cell Signaling
Estefania Moreno et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Mechanism of platelet activation induced by endocannabinoids in blood and plasma
S. Annette Brantl et al.
PLATELETS (2014)
Inhibition of Fatty Acid Binding Proteins Elevates Brain Anandamide Levels and Produces Analgesia
Martin Kaczocha et al.
PLOS ONE (2014)
Involvement of Fatty Acid Amide Hydrolase and Fatty Acid Binding Protein 5 in the Uptake of Anandamide by Cell Lines with Different Levels of Fatty Acid Amide Hydrolase Expression: A Pharmacological Study
Emmelie Bjorklund et al.
PLOS ONE (2014)
Δ9-THC modulation of fatty acid 2-hydroxylase (FA2H) gene expression: Possible involvement of induced levels of PPARα in MDA-MB-231 breast cancer cells
Shuso Takeda et al.
TOXICOLOGY (2014)
Significance of downregulation of liver fatty acid-binding protein in hepatocellular carcinoma
Masafumi Inoue et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
Crystallographic study of FABP5 as an intracellular endocannabinoid transporter
Benoit Sanson et al.
ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY (2014)
Cannabinoid receptor-2 immunoreactivity is associated with survival in squamous cell carcinoma of the head and neck
Thomas J. W. Klein Nulent et al.
BRITISH JOURNAL OF ORAL & MAXILLOFACIAL SURGERY (2013)
Genetic Ablation of the Fatty Acid-Binding Protein FABP5 Suppresses HER2-Induced Mammary Tumorigenesis
Liraz Levi et al.
CANCER RESEARCH (2013)
Triggering of the TRPV2 channel by cannabidiol sensitizes glioblastoma cells to cytotoxic chemotherapeutic agents
Massimo Nabissi et al.
CARCINOGENESIS (2013)
Cannabinoid CB1 receptor is expressed in chromophobe renal cell carcinoma and renal oncocytoma
Gorka Larrinaga et al.
CLINICAL BIOCHEMISTRY (2013)
Anticancer activity of anandamide in human cutaneous melanoma cells
Barbara Adinolfi et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2013)
Omega-3 PUFA ethanolamides DHEA and EPEA induce autophagy through PPARγ activation in MCF-7 breast cancer cells
Daniela Rovito et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2013)
PPARγ mediates the effects of WIN55,212-2, an synthetic cannabinoid, on the proliferation and apoptosis of the BEL-7402 hepatocarcinoma cells
Yuehui Hong et al.
MOLECULAR BIOLOGY REPORTS (2013)
COX-2 and PPAR-γ Confer Cannabidiol-Induced Apoptosis of Human Lung Cancer Cells
Robert Ramer et al.
MOLECULAR CANCER THERAPEUTICS (2013)
Potential tumor-suppressive role of monoglyceride lipase in human colorectal cancer
H. Sun et al.
ONCOGENE (2013)
A Gut Lipid Messenger Links Excess Dietary Fat to Dopamine Deficiency
Luis A. Tellez et al.
SCIENCE (2013)
Direct modulation of the outer mitochondrial membrane channel, voltage-dependent anion channel 1 (VDAC1) by cannabidiol: a novel mechanism for cannabinoid-induced cell death
N. Rimmerman et al.
CELL DEATH & DISEASE (2013)
Involvement of PPARγ in the antitumoral action of cannabinoids on hepatocellular carcinoma
D. Vara et al.
CELL DEATH & DISEASE (2013)
Expression of the cannabinoid type I receptor and prognosis following surgery in colorectal cancer
Chan Kwon Jung et al.
ONCOLOGY LETTERS (2013)
Bone marrow adipocytes promote tumor growth in bone via FABP4-dependent mechanisms
Mackenzie K. Herroon et al.
ONCOTARGET (2013)
N-Arachidonyl Glycine Does Not Activate G Protein-Coupled Receptor 18 Signaling via Canonical Pathways
Van B. Lu et al.
MOLECULAR PHARMACOLOGY (2013)
Cannabinoid actions at TRPV channels: effects on TRPV3 and TRPV4 and their potential relevance to gastrointestinal inflammation
L. De Petrocellis et al.
ACTA PHYSIOLOGICA (2012)
The association of N-palmitoylethanolamine with the FAAH inhibitor URB597 impairs melanoma growth through a supra-additive action
Laurie Hamtiaux et al.
BMC CANCER (2012)
Δ9-Tetrahydrocannabinol and N-arachidonyl glycine are full agonists at GPR18 receptors and induce migration in human endometrial HEC-1B cells
Douglas McHugh et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
Anandamide inhibits the Wnt/β-catenin signalling pathway in human breast cancer MDA MB 231 cells
Chiara Laezza et al.
EUROPEAN JOURNAL OF CANCER (2012)
Cannabidiol inhibits lung cancer cell invasion and metastasis via intercellular adhesion molecule-1
Robert Ramer et al.
FASEB JOURNAL (2012)
Fatty Acid-binding Proteins Transport N-Acylethanolamines to Nuclear Receptors and Are Targets of Endocannabinoid Transport Inhibitors
Martin Kaczocha et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Overexpression of FABP3 promotes apoptosis through inducing mitochondrial impairment in embryonic cancer cells
Gui Xian Song et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2012)
Interaction of Endocannabinoid System and Steroid Hormones in the Control of Colon Cancer Cell Growth
Maria C. Proto et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2012)
Chemopreventive effect of the non-psychotropic phytocannabinoid cannabidiol on experimental colon cancer
Gabriella Aviello et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2012)
Alteration of endocannabinoid system in human gliomas
Xiyue Wu et al.
JOURNAL OF NEUROCHEMISTRY (2012)
Why do cannabinoid receptors have more than one endogenous ligand?
Vincenzo Di Marzo et al.
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES (2012)
Effects of cannabinoids and cannabinoid-enriched Cannabis extracts on TRP channels and endocannabinoid metabolic enzymes
Luciano De Petrocellis et al.
BRITISH JOURNAL OF PHARMACOLOGY (2011)
Monoacylglycerol lipase (MAGL) knockdown inhibits tumor cells growth in colorectal cancer
Lin Ye et al.
CANCER LETTERS (2011)
Monoacylglycerol Lipase Exerts Dual Control over Endocannabinoid and Fatty Acid Pathways to Support Prostate Cancer
Daniel K. Nomura et al.
CHEMISTRY & BIOLOGY (2011)
A Combined Preclinical Therapy of Cannabinoids and Temozolomide against Glioma
Sofia Torres et al.
MOLECULAR CANCER THERAPEUTICS (2011)
Minireview: Recent Developments in the Physiology and Pathology of the Lysophosphatidylinositol-Sensitive Receptor GPR55
Christopher M. Henstridge et al.
MOLECULAR ENDOCRINOLOGY (2011)
Increasing Antiproliferative Properties of Endocannabinoids in N1E-115 Neuroblastoma Cells through Inhibition of Their Metabolism
Laurie Hamtiaux et al.
PLOS ONE (2011)
Anti-proliferative effect of a putative endocannabinoid, 2-arachidonylglyceryl ether in prostate carcinoma cells
Kasem Nithipatikom et al.
PROSTAGLANDINS & OTHER LIPID MEDIATORS (2011)
Endocannabinoid Hydrolysis Generates Brain Prostaglandins That Promote Neuroinflammation
Daniel K. Nomura et al.
SCIENCE (2011)
L-α-Lysophosphatidylinositol meets GPR55: a deadly relationship
Ruth A. Ross
TRENDS IN PHARMACOLOGICAL SCIENCES (2011)
Pharmacology of capsaicin-, anandamide-, and N-arachidonoyl-dopamine-evoked cell death in a homogeneous transient receptor potential vanilloid subtype 1 receptor population
J. W. Davies et al.
BRITISH JOURNAL OF ANAESTHESIA (2010)
Cannabinoid receptor-dependent and -independent anti-proliferative effects of omega-3 ethanolamides in androgen receptor-positive and -negative prostate cancer cell lines
Iain Brown et al.
CARCINOGENESIS (2010)
Monoacylglycerol Lipase Regulates a Fatty Acid Network that Promotes Cancer Pathogenesis
Daniel K. Nomura et al.
CELL (2010)
The Levels of the Endocannabinoid Receptor CB2 and Its Ligand 2-Arachidonoylglycerol Are Elevated in Endometrial Carcinoma
Maurizio Guida et al.
ENDOCRINOLOGY (2010)
Brain Fatty Acid-binding Protein and ω-3/ω-6 Fatty Acids MECHANISTIC INSIGHT INTO MALIGNANT GLIOMA CELL MIGRATION
Raja Mita et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Fatty Acid-binding Protein 5 and PPARβ/δ Are Critical Mediators of Epidermal Growth Factor Receptor-induced Carcinoma Cell Growth
Padmamalini Kannan-Thulasiraman et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Cannabinoid CB1 Receptor Is Downregulated in Clear Cell Renal Cell Carcinoma
Gorka Larrinaga et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2010)
Fatty-acid-binding protein 5 promotes cell proliferation and invasion in oral squamous cell carcinoma
Lei-Ya Fang et al.
JOURNAL OF ORAL PATHOLOGY & MEDICINE (2010)
The Synthetic Cannabinoid WIN 55,212-2 Sensitizes Hepatocellular Carcinoma Cells to Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL)-Induced Apoptosis by Activating p8/CCAAT/Enhancer Binding Protein Homologous Protein (CHOP)/Death Receptor 5 (DR5) Axis
O. Pellerito et al.
MOLECULAR PHARMACOLOGY (2010)
Mammary-derived growth inhibitor (MDGI) interacts with integrin α-subunits and suppresses integrin activity and invasion
J. Nevo et al.
ONCOGENE (2010)
Fatty Acid Amide Hydrolase in Prostate Cancer: Association with Disease Severity and Outcome, CB1 Receptor Expression and Regulation by IL-4
Lina Thors et al.
PLOS ONE (2010)
Apoptosis induced in HepG2 cells by the synthetic cannabinoid WIN: Involvement of the transcription factor PPARγ
Michela Giuliano et al.
BIOCHIMIE (2009)
Brain-type and liver-type fatty acid-binding proteins: new tumor markers for renal cancer?
Angelika Toelle et al.
BMC CANCER (2009)
A high cannabinoid CB1 receptor immunoreactivity is associated with disease severity and outcome in prostate cancer
Sui Chu Chung et al.
EUROPEAN JOURNAL OF CANCER (2009)
Time-dependent vascular actions of cannabidiol in the rat aorta
Saoirse E. O'Sullivan et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2009)
Lipid G Protein-coupled Receptor Ligand Identification Using β-Arrestin PathHunter™ Assay
Hong Yin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Increased expressions of cannabinoid receptor-1 and transient receptor potential vanilloid-1 in human prostate carcinoma
Gabriella Czifra et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2009)
Cannabidiol Attenuates Cisplatin-Induced Nephrotoxicity by Decreasing Oxidative/Nitrosative Stress, Inflammation, and Cell Death
Hao Pan et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2009)
R(+)-Methanandamide-Induced Apoptosis of Human Cervical Carcinoma Cells Involves A Cyclooxygenase-2-Dependent Pathway
Karin Eichele et al.
PHARMACEUTICAL RESEARCH (2009)
The endocannabinoid system: Its general strategy of action, tools for its pharmacological manipulation and potential therapeutic exploitation
Vincenzo Di Marzo
PHARMACOLOGICAL RESEARCH (2009)
Identification of intracellular carriers for the endocannabinoid anandamide
Martin Kaczocha et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Biology of endocannabinoid synthesis system
Jun Wang et al.
PROSTAGLANDINS & OTHER LIPID MEDIATORS (2009)
Influence of dietary fatty acids on endocannabinoid and N-acylethanolamine levels in rat brain, liver and small intestine
Andreas Artmann et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2008)
Loss of cannabinoid receptor 1 accelerates intestinal tumor growth
Dingzhi Wang et al.
CANCER RESEARCH (2008)
Cannabinoids in pancreatic cancer:: Correlation with survival and pain
Christoph W. Michalski et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Expression and function of fatty acid amide hydrolase in prostate cancer
Michael P. Endsley et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Expression and Secretion of N-acylethanolamine-hydrolysing Acid Amidase in Human Prostate Cancer Cells
Jun Wang et al.
JOURNAL OF BIOCHEMISTRY (2008)
Identification of farnesyl pyrophosphate and N-arachidonylglycine as endogenous ligands for GPR92
Da Young Oh et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
TRPV2 is activated by cannabidiol and mediates CGRP release in cultured rat dorsal root ganglion neurons
Ning Qin et al.
JOURNAL OF NEUROSCIENCE (2008)
Plant-derived cannabinoids modulate the activity of transient receptor potential channels of ankyrin type-1 and melastatin type-8
Luciano De Petrocellis et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2008)
Inhibition of cancer cell invasion by cannabinoids via increased expression of tissue inhibitor of matrix metalloproteinases-1
Robert Ramer et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2008)
Enhancing the in vitro cytotoxic activity of Delta(9)-tetrahydrocannabinol in leukemic cells through a combinatorial approach
Wai M. Liu et al.
LEUKEMIA & LYMPHOMA (2008)
Multiple pathways involved in the biosynthesis of anandamide
Jie Liu et al.
NEUROPHARMACOLOGY (2008)
GPR55 is a cannabinoid receptor that increases intracellular calcium and inhibits M current
Jane E. Lauckner et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Increased endocannabinoid levels reduce the development of precancerous lesions in the mouse colon
Angelo A. Izzo et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2008)
The novel endocannabinoid receptor GPR55 is activated by atypical cannabinoids but does not mediate their vasodilator effects
D. G. Johns et al.
BRITISH JOURNAL OF PHARMACOLOGY (2007)
The orphan receptor GPR55 is a novel cannabinoid receptor
E. Ryberg et al.
BRITISH JOURNAL OF PHARMACOLOGY (2007)
The multidrug transporter ABCG2 (BCRP) is inhibited by plant-derived cannabinoids
M. L. Holland et al.
BRITISH JOURNAL OF PHARMACOLOGY (2007)
A comprehensive profile of brain enzymes that hydrolyze the endocannabinoid 2-arachidonoylglycerol
Jacqueline L. Blankman et al.
CHEMISTRY & BIOLOGY (2007)
Cannabinoid activation of PPARα;: a novel neuroprotective mechanism
Y. Sun et al.
BRITISH JOURNAL OF PHARMACOLOGY (2007)
Discovery and characterization of Ca2+-independent phosphatidylethanolarnine N-acyltransferase generating the anandarnide precursor and its congeners
Xing-Hua Jin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Expression of cannabinoid receptors and neurotrophins in human gliomas
C. Calatozzolo et al.
NEUROLOGICAL SCIENCES (2007)
Cannabinoid receptors as novel targets for the treatment of melanoma
Cristina Blazquez et al.
FASEB JOURNAL (2006)
Anandamide inhibits Cdk2 and activates Chk1 leading to cell cycle arrest in human breast cancer cells
Chlara Laezza et al.
FEBS LETTERS (2006)
Overexpression of cannabinoid receptors CB1 and CB2 correlates with improved prognosis of patients with hepatocellular carcinoma
Xundi Xu et al.
CANCER GENETICS AND CYTOGENETICS (2006)
Cannabinoid receptor-mediated apoptosis induced by R(+)-methanandamide and Win55,212-2 is associated with ceramide accumulation and p38 activation in mantle cell lymphoma
Kristin Gustafsson et al.
MOLECULAR PHARMACOLOGY (2006)
Antitumor activity of plant cannabinoids with emphasis on the effect of cannabidiol on human breast carcinoma
Alessia Ligresti et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)
A pilot clinical study of Δ9- tetrahydrocannabinol in patients with recurrent glioblastoma multiforme
M. Guzman et al.
BRITISH JOURNAL OF CANCER (2006)
The effects of cannabinoids on P-glycoprotein transport and expression in multidrug resistant cells
ML Holland et al.
BIOCHEMICAL PHARMACOLOGY (2006)
Further characterization of the time-dependent vascular effects of Δ9-tetrahydrocannabinol
SE O'Sullivan et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)
Deorphanization of a G protein-coupled receptor for oleoylethanolamide and its use in the discovery of small-molecule hypophagic agents
HA Overton et al.
CELL METABOLISM (2006)
Anandamide inhibits adhesion and migration of breast cancer cells
C Grimaldi et al.
EXPERIMENTAL CELL RESEARCH (2006)
R(+)-methanandamide elicits a cyclooxygenase-2-dependent mitochondrial apoptosis signaling pathway in human neuroglioma cells
K Eichele et al.
PHARMACEUTICAL RESEARCH (2006)
Novel time-dependent vascular actions of Δ9-tetrahydrocannabinol mediated by peroxisome proliferator-activated receptor gamma
SE O'Sullivan et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)
Involvement of N-acylethanolamine-hydrolyzing acid amidase in the degradation of anandamide and other N-acylethanolamines in macrophages
YX Sun et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2005)
Fatty acid amidohydrolase in human neocortex-activity in epileptic and non-epileptic brain tissue and inhibition by putative endocannabinoids
M Steffens et al.
NEUROSCIENCE LETTERS (2005)
Anandamide induced PPARγ transcriptional activation and 3T3-L1 preadipocyte differentiation
M Bouaboula et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2005)
Endocannabinoid metabolism in human glioblastomas and meningiomas compared to human non-tumour brain tissue
G Petersen et al.
JOURNAL OF NEUROCHEMISTRY (2005)
Δ-9-tetrahydrocannabinol enhances breast cancer growth and metastasis by suppression of the antitumor immune response
RJ McKallip et al.
JOURNAL OF IMMUNOLOGY (2005)
The nuclear receptor peroxisome proliferator-activated receptor-alpha mediates the anti-inflammatory actions of palmitoylethanolamide
J Lo Verme et al.
MOLECULAR PHARMACOLOGY (2005)
Arachidonyl ethanolamide induces apoptosis of uterine cervix cancer cells via aberrantly expressed vanilloid receptor-1
E Contassot et al.
GYNECOLOGIC ONCOLOGY (2004)
A new strategy to block tumor growth by inhibiting endocannabinoid inactivation
M Bifulco et al.
FASEB JOURNAL (2004)
2-arachidonoylglycerol: A novel inhibitor of androgen-independent prostate cancer cell invasion
K Nithipatikom et al.
CANCER RESEARCH (2004)
Up-regulation of cyclooxygenase-2 expression is involved in R(+)-methanandamide-induced apoptotic death of human neuroglioma cells
B Hinz et al.
MOLECULAR PHARMACOLOGY (2004)
Assignment of endogenous substrates to enzymes by global metabolite profiling
A Saghatelian et al.
BIOCHEMISTRY (2004)
Noladin ether, a putative endocannabinoid, attenuates sensory neurotransmilssion in the rat isolated mesenteric arterial bed via a non-CB1/CB2Gi/o linked receptor
M Duncan et al.
BRITISH JOURNAL OF PHARMACOLOGY (2004)
Oleylethanolamide regulates feeding and body weight through activation of the nuclear receptor PPAR-α
J Fu et al.
NATURE (2003)
Possible endocannabinoid control of colorectal cancer growth
A Ligresti et al.
GASTROENTEROLOGY (2003)
Inhibitory effects of cannabinoid CB1 receptor stimulation on tumor growth and metastatic spreading:: actions on signals involved in angiogenesis and metastasis
G Portella et al.
FASEB JOURNAL (2003)
Anti-proliferative and apoptotic effects of anandamide in human prostatic cancer cell lines:: Implication of epidermal growth factor receptor down-regulation and ceramide production
M Mimeault et al.
PROSTATE (2003)
Anandamide and other N-acylethanolamines in human tumors
PC Schmid et al.
LIPIDS (2002)
Binding, degradation and apoptotic activity of stearoylethanolamide in rat C6 glioma cells
M Maccarrone et al.
BIOCHEMICAL JOURNAL (2002)
Effect on cancer cell proliferation of palmitoylethanolamide, a fatty acid amide interacting with both the cannabinoid and vanilloid signalling systems
L De Petrocellis et al.
FUNDAMENTAL & CLINICAL PHARMACOLOGY (2002)
An endogenous capsaicin-like substance with high potency at recombinant and native vanilloid VR1 receptors
SM Huang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Characterization of a novel endocannabinoid, virodhamine, with antagonist activity at the CB1 receptor
AC Porter et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2002)
2-arachidonoyl-sn-glycero-3-phosphate, an arachidonic acid-containing lysophosphatidic acid:: occurrence and rapid enzymatic conversion to 2-arachidonoyl-sn-glycerol, a cannabinoid receptor ligand, in rat brain
S Nakane et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2002)
Anandamide receptors
V Di Marzo et al.
PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS (2002)
Control by the endogenous cannabinoid system of ras oncogene-dependent tumor growth
M Bifulco et al.
FASEB JOURNAL (2001)
Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide
T Bisogno et al.
BRITISH JOURNAL OF PHARMACOLOGY (2001)
Despite substantial degradation, 2-arachidonoylglycerol is a potent full efficacy agonist mediating CB1 receptor-dependent G-protein activation in rat cerebellar membranes
JR Savinainen et al.
BRITISH JOURNAL OF PHARMACOLOGY (2001)
2-Arachidonyl glyceryl ether, an endogenous agonist of the cannabinoid CB1 receptor
L Hanus et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Gas chromatography-mass spectrometry analysis of endogenous cannabinoids in healthy and tumoral human brain and human cells in culture
M Maccarrone et al.
JOURNAL OF NEUROCHEMISTRY (2001)
Pathways and mechanisms of N-acylethanolamine biosynthesis:: can anandamide be generated selectively?
HHO Schmid
CHEMISTRY AND PHYSICS OF LIPIDS (2000)
Oxygenation of the endocannabinoid, 2-arachidonylglycerol, to glyceryl prostaglandins by cyclooxygenase-2
KR Kozak et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Anandamide induces apoptosis in human cells via vanilloid receptors -: Evidence for a protective role of cannabinoid receptors
M Maccarrone et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Δ-9-tetrahydrocannabinol inhibits antitumor immunity by a CB2 receptor-mediated, cytokine-dependent pathway
LX Zhu et al.
JOURNAL OF IMMUNOLOGY (2000)
Evidence that 2-arachidonoylglycerol but not N-palmitoylethanolamine or anandamide is the physiological ligand for the cannabinoid CB2 receptor -: Comparison of the agonistic activities of various cannabinoid receptor ligands in HL-60 cells
T Sugiura et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
分享论文
